Bio-Techne (TECH) Income from Continuing Operations (2016 - 2025)
Historic Income from Continuing Operations for Bio-Techne (TECH) over the last 17 years, with Q4 2025 value amounting to $38.0 million.
- Bio-Techne's Income from Continuing Operations rose 893.95% to $38.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $30.0 million, marking a year-over-year decrease of 7461.18%. This contributed to the annual value of $22.2 million for FY2025, which is 8261.11% down from last year.
- Latest data reveals that Bio-Techne reported Income from Continuing Operations of $38.0 million as of Q4 2025, which was up 893.95% from $38.2 million recorded in Q3 2025.
- Bio-Techne's 5-year Income from Continuing Operations high stood at $89.7 million for Q3 2022, and its period low was -$68.8 million during Q2 2025.
- For the 5-year period, Bio-Techne's Income from Continuing Operations averaged around $38.9 million, with its median value being $45.5 million (2021).
- In the last 5 years, Bio-Techne's Income from Continuing Operations soared by 56312.36% in 2022 and then crashed by 1621943.79% in 2025.
- Over the past 5 years, Bio-Techne's Income from Continuing Operations (Quarter) stood at $72.1 million in 2021, then plummeted by 30.61% to $50.0 million in 2022, then plummeted by 45.08% to $27.5 million in 2023, then increased by 27.03% to $34.9 million in 2024, then rose by 8.94% to $38.0 million in 2025.
- Its Income from Continuing Operations was $38.0 million in Q4 2025, compared to $38.2 million in Q3 2025 and -$68.8 million in Q2 2025.